Chemical and Drug Induced Liver Injury clinical trials
The registry lists 80 studies for Chemical and Drug Induced Liver Injury across more than 10 countries. 21 are recruiting or about to start. 60 of them are mainly about Chemical and Drug Induced Liver Injury (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.
Get an email when these change. Save the Chemical and Drug Induced Liver Injury studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Who runs them
Beijing 302 Hospital (8) · Drug Induced Liver Disease Study Group (6) · Beijing Friendship Hospital (4) · Assiut University (4) · Massachusetts General Hospital (2) · Institute of Liver and Biliary Sciences, India (2) · Seoul National University Hospital (2) · Oxford University Clinical Research Unit, Vietnam (2)
What is being tested here
Drugs under test in Chemical and Drug Induced Liver Injury studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Acetylcysteine | 1 | 2 | 6 |
| Methylprednisolone | 1 | 0 | 2 |
| Silymarin | 1 | 0 | 2 |
| S-Adenosylmethionine | 1 | 0 | 1 |
| Methylprednisolone Hemisuccinate | 1 | 0 | 1 |
| Bicyclol | 0 | 1 | 3 |
| Dexamethasone | 0 | 2 | 2 |
| Acetaminophen | 0 | 0 | 2 |
| Cannabidiol | 0 | 0 | 1 |
| Citalopram | 0 | 0 | 1 |
Drug classes tested here Corticosteroids 2 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 6, phase 3 first
- Jun 2027Misocholic Tablets for Non-Viral Elevated Liver Enzymes · Phase 3 · Hanoi Medical University
- Dec 2026A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases · Institute of Hematology & Blood Diseases Hospital, China
- Dec 2026A Prognostic Model for Drug-induced Liver Injury in China · Beijing Friendship Hospital
- Mar 2027Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia · General Hospital of Shenyang Military Region
- May 2027Drug-induced Liver Injury: Itching Study · University of Nottingham
- Oct 2027Prevalence and Prognosis of Drug-Induced Liver Injury · Assiut University
Who these studies take
Of the 12 Chemical and Drug Induced Liver Injury studies recruiting now, 7 (58%) set no upper age limit and 3 (25%) stop at 75 or younger. 3 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (8%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (17%) | 2 (17%) |
| 18 | 12 (100%) | 12 (100%) |
| 30 | 12 (100%) | 12 (100%) |
| 40 | 12 (100%) | 12 (100%) |
| 50 | 12 (100%) | 12 (100%) |
| 65 | 12 (100%) | 12 (100%) |
| 75 | 10 (83%) | 10 (83%) |
| 85 | 8 (67%) | 8 (67%) |
Across all 80 studies, recruiting or not: 41% stop at 75 or younger and 11% at 65; 19% take children; 3% are for women only and 0% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 80. Browse all 80 → or search them.
- SAMe in Prevention of Oxaliplatin-associated Liver InjuryNot yet recruitingNCT06258525Phase 21 country
- Silymarin Versus N-Acetylcysteine as Protective Effect Against Anti-tuberculosis Drugs Induced Liver Injury.Not yet recruitingNCT07875322Early Phase 11 country
- Misocholic Tablets for Non-Viral Elevated Liver EnzymesNot yet recruitingNCT07833514Phase 31 country
- Prevalence and Prognosis of Drug-Induced Liver InjuryNot yet recruitingNCT07830901
- Drug-induced Liver Injury: Itching StudyRecruitingNCT064466091 country
- Prospective Cohort of Immune Checkpoint Inhibitor-induced HepatitisRecruitingNCT068644811 country
- Drug-Induced Liver Injury (DILI) Network RetrospectiveRecruitingNCT003606461 country
- A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological DiseasesNot yet recruitingNCT07476885
- Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and PredictorsNot yet recruitingNCT074723481 country
- Glucocorticoids for Acute Drug Induced Liver Injury With HyperbilirubinemiaRecruitingNCT06922669Not applicable1 country
- A Prognostic Model for Drug-induced Liver Injury in ChinaRecruitingNCT050602891 country
- Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , KarachiNot yet recruitingNCT07058090Phase 1
- A Prospective Cohort Study on Drug-induced Liver Injury in China(DILI-P)RecruitingNCT029614131 country
- Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control StudyRecruitingNCT049643101 country
- Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver DiseaseNot yet recruitingNCT06797011Phase 2/31 country
- Prospective Comparative Validation Study of RUCAM and RECAMRecruitingNCT067710111 country
- Livertoxcicity in Acute Leukemia Patients During Chemotherapy TreatmentNot yet recruitingNCT06383325
- A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI SubjectsRecruitingNCT06019936Phase 21 country
- Alterations of Gut Microbiota and Serum Biochemical Markers in DILI PatientsRecruitingNCT054656421 country
- Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related HepatitisRecruitingNCT04810156Phase 21 country
- Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control TrialRecruitingNCT04553003Phase 41 country
- Digoxin In Treatment of Alcohol Associated HepatitisTerminatedNCT05014087Phase 21 country
- Discrimination of DILI and AIH by Artificial IntelligenceCompletedNCT055323451 country
- miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 TrialCompletedNCT06285253Phase 11 country
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to PlaceboCompletedNCT05144217Phase 2/31 country
- Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen OverdoseTerminatedNCT05517668Phase 21 country
- A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient SettingTerminatedNCT042694861 country
- Remaxol® in Patients With Drug-induced Liver Injuries During Cancer ChemotherapyCompletedNCT057897971 country
- Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug InteractionsCompletedNCT06192589Phase 11 country
- Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous MeningitisCompletedNCT03100786Phase 31 country
- A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic AgentsActive, not recruitingNCT066703911 country
- Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver FailureActive, not recruitingNCT06872372Not applicable1 country
- Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver InjuryActive, not recruitingNCT065472291 country
- Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis DrugsActive, not recruitingNCT065394551 country
- Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis PatientsCompletedNCT032112081 country
- Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)CompletedNCT03092817Phase 32 countries
- Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled TrialStatus unknownNCT05738681Phase 2/31 country
- 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILICompletedNCT03266146Phase 1/21 country
- Bicyclol in the Treatment of Antineoplastic Drug-induced Liver Injury.Status unknownNCT05711459Not applicable1 country
- The Multi-Center, Randomized, Double-blind, Positive Controlled Clinical Trial of Bicyclol in the Treatment of Acute DILIStatus unknownNCT05063500Phase 31 country
- Combi-elastography Assessment of Chronic Liver Disease Multi-center StudyStatus unknownNCT046251661 country
- Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver InjuryCompletedNCT04595916Phase 41 country
- A Diagnostic Study on Patients With Drug-induced Liver InjuryStatus unknownNCT04526548
- Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILICompletedNCT02651350Phase 1/21 country
- The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILICompletedNCT02944552Phase 21 country
- Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral DrugsCompletedNCT036027031 country
- Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver InjuryStatus unknownNCT043025061 country
- A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism StatusCompletedNCT03665402Not applicable1 country
- Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and HepatotoxicityStatus unknownNCT023534555 countries
- Hepatotoxicity of Antituberculosis Therapy (HAT) StudyStatus unknownNCT04159441